EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieBeobachtungsstudieKohortenstudieOpen Access

Intensive Versus Moderate Statin‐Based Therapies in Patients With Mild Ischemic Stroke: A Prospective Multicenter Cohort Study

Hai-Mei Fan iD, Yong-le Wang iD, Kai-Li Zhang, Ting-Ting Liu iD, Xin-Yi Li, Ya-Nan Li, Ya-Li Li, Juan Li, Jing Ren, Yu-Ting Liu, Jun-Hui Wang, Li-Xi Xue und 8 weitere

Journal of the American Heart Association · 16.07.2024 · 13 (14)

DOI: 10.1161/jaha.124.035337 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 16.07.2024. Verfasst von Hai-Mei Fan und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology First Hospital of Shanxi Medical University Taiyuan China. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Ischemic Stroke, Recurrence. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Statins are widely used for treating patients with ischemic stroke at risk of secondary cerebrovascular events. It is unknown whether Asian populations benefit from more intensive statin‐based therapy for stroke recurrence. Therefore, in the present study we evaluated the effectiveness and safety of high‐dose and moderate‐dose statins for patients who had experienced mild ischemic stroke during the acute period. Methods and Results This multicenter prospective study included patients with mild ischemic stroke who presented within 72 hours of symptom onset. The outcomes of patients in the high‐intensity and moderate‐intensity statin treatment groups were compared, with the main efficacy outcome being stroke recurrence and the primary safety end point being intracranial hemorrhage. The propensity score matching method was employed to control for imbalances in baseline variables. Subgroup analyses were conducted to evaluate group differences. In total, the data of 2950 patients were analyzed at 3 months, and the data of 2764 patients were analyzed at 12 months due to loss to follow‐up. According to the multivariable Cox analyses adjusted for potential confounders, stroke recurrence occurred similarly in the high‐intensity statin and moderate‐intensity statin groups (3 months: adjusted hazard ratio [HR], 1.12 [95% CI, 0.85–1.49]; P =0.424; 12 months: adjusted HR, 1.08 [95% CI, 0.86–1.34]; P =0.519). High‐intensity statin therapy was associated with an increased risk of intracranial hemorrhage (3 months: adjusted HR, 1.81 [95% CI, 1.00–3.25]; P =0.048; 12 months: adjusted HR, 1.86 [95% CI, 1.10–3.16]; P =0.021). The results from the propensity score‐matched analyses were consistent with those from the Cox proportional hazards analysis.

Conclusions

Compared with moderate‐intensity statin therapy, high‐dose statin therapy may not decrease the risk of mild, noncardiogenic ischemic stroke recurrence but may increase the risk of intracranial hemorrhage. Registration URL: www.chictr.org.cn/ . Unique Identifier: ChiCTR1900025214.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsIschemic StrokeRecurrenceHumansFemaleMaleProspective StudiesAgedMiddle AgedTreatment OutcomeTime FactorsRisk FactorsPropensity ScoreIntracranial HemorrhagesSeverity of Illness IndexSecondary Prevention

Stichwörter der Autor:innen

Chinafollow‐up studieshydroxymethylglutaryl‐CoA reductase inhibitorsintracranial hemorrhagesischemic strokeprospective studies

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Neurology First Hospital of Shanxi Medical University Taiyuan China.
  • Department of Neurology General Hospital of Tisco (Sixth Hospital of Shanxi Medical University) Taiyuan China.
  • Department of Neurology Shanxi Bethune Hospital (Third Hospital of Shanxi Medical University) Taiyuan China.
  • Department of Neurology General Hospital of Central Theater Command of the People's Liberation Army Wuhan China.
  • Department of Neurology Cangzhou Central Hospital Cangzhou China.
  • Department of Neurology Shanxi Cardiovascular Hospital Taiyuan China.

ORCID-Profile: Hai-Mei Fan, Yong-le Wang, Ting-Ting Liu, Xiao-Yuan Niu

Zitieren

APA

Fan, H. M., Wang, Y. L., Zhang, K. L., Liu, T. T., Li, X. Y., Li, Y. N., Li, Y. L., Li, J., Ren, J., Liu, Y. T., Wang, J. H., Xue, L. X., Du, W. X., Niu, W. H., Yan, Y. P., Gao, X. L., Liu, Q. P., Li, G. M., Wu, X. M., & Niu, X. Y. (2024). Intensive Versus Moderate Statin‐Based Therapies in Patients With Mild Ischemic Stroke: A Prospective Multicenter Cohort Study. Journal of the American Heart Association, 13(14). https://doi.org/10.1161/jaha.124.035337

Vancouver

Fan HM, Wang YL, Zhang KL, Liu TT, Li XY, Li YN, et al. Intensive Versus Moderate Statin‐Based Therapies in Patients With Mild Ischemic Stroke: A Prospective Multicenter Cohort Study. Journal of the American Heart Association. 2024;13(14). doi:10.1161/jaha.124.035337

BibTeX
@article{Fan2024,
  author = {Fan, Hai-Mei and Wang, Yong-le and Zhang, Kai-Li and Liu, Ting-Ting and Li, Xin-Yi and Li, Ya-Nan and Li, Ya-Li and Li, Juan and Ren, Jing and Liu, Yu-Ting and Wang, Jun-Hui and Xue, Li-Xi and Du, Wen-Xian and Niu, Wen-Hua and Yan, Yu-Ping and Gao, Xiao-Lei and Liu, Qing-Ping and Li, Gai-Mei and Wu, Xue-Mei and Niu, Xiao-Yuan},
  title = {Intensive Versus Moderate Statin‐Based Therapies in Patients With Mild Ischemic Stroke: A Prospective Multicenter Cohort Study},
  journal = {Journal of the American Heart Association},
  year = {2024},
  volume = {13},
  number = {14},
  doi = {10.1161/jaha.124.035337}
}
Kostenlos starten →